Theratechnologies (Theratechnologies) Long-Term Debt : $45.90 Mil (As of Feb. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Long-Term Debt?

Theratechnologies's Long-Term Debt for the quarter that ended in Feb. 2024 was $45.90 Mil.

Theratechnologies's quarterly Long-Term Debt increased from Aug. 2023 ($0.00 Mil) to Nov. 2023 ($50.69 Mil) but then declined from Nov. 2023 ($50.69 Mil) to Feb. 2024 ($45.90 Mil).

Theratechnologies's annual Long-Term Debt declined from Nov. 2021 ($54.23 Mil) to Nov. 2022 ($0.00 Mil) but then increased from Nov. 2022 ($0.00 Mil) to Nov. 2023 ($50.69 Mil).

Theratechnologies Long-Term Debt Historical Data

The historical data trend for Theratechnologies's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Long-Term Debt Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Long-Term Debt

Get a 7-Day Free Trial

50.74

52.40

54.23

50.69

Theratechnologies Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Long-Term Debt	Get a 7-Day Free Trial															37.96	38.11	-	50.69	45.90

Theratechnologies (NAS:THTX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Theratechnologies Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.